|
1
|
Castellani RJ, Rolston RK and Smith MA:
Alzheimer disase. Dis Mon. 56:484–546. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Gatz M, Reynolds CA, Fratiglioni L,
Johansson B, Mortimer JA, Berg S, Fiske A and Pedersen NL: Role of
genes and environments for explaining Alzheimer disease. Arch Gen
Psychiat. 63:168–174. 2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Naj AC and Schellenberg GD: Alzheimer's
Disease Genetics Consortium (ADGC). Genomic variants, genes, and
pathways of Alzheimer's disease: An overview. Am J Med Genet B
Neuropsychiatr Genet. 174:5–26. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jonsson T, Stefansson H, Steinberg S,
Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J,
Levey AI, Lah JJ, et al: Variant of TREM2 associated with the risk
of Alzheimer's disease. New Engl J Med. 368:107–116.
2013.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sims R, van der Lee SJ, Naj AC, Bellenguez
C, Badarinarayan N, Jakobsdottir J, Kunkle BW, Boland A, Raybould
R, Bis JC, et al: Rare coding variants in PLCG2, ABI3, and TREM2
implicate microglial-mediated innate immunity in Alzheimer's
disease. Nat Genet. 49:1373–1384. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
6
|
Rohn TT: The triggering receptor expressed
on myeloid cells 2: ‘TREM-ming’ the inflammatory component
associated with Alzheimer's disease. Oxid Med Cell Longev.
2013(860959)2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Paloneva J, Manninen T, Christman G,
Hovanes K, Mandelin J, Adolfsson R, Bianchin M, Bird T, Miranda R,
Salmaggi A, et al: Mutations in two genes encoding different
subunits of a receptor signaling complex result in an identical
disease phenotype. Am J Hum Genet. 71:656–662. 2002.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Guerreiro R, Wojtas A, Bras J,
Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe
JS, Younkin S, et al: TREM2 variants in Alzheimer's disease. N Engl
J Med. 368:117–127. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Jin SC, Carrasquillo MM, Benitez BA,
Skorupa T, Carrell D, Patel D, Lincoln S, Krishnan S, Kachadoorian
M, Reitz C, et al: TREM2 is associated with increased risk for
Alzheimer's disease in African Americans. Mol Neurodegener.
10(19)2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Miyashita A, Wen Y, Kitamura N, Matsubara
E, Kawarabayashi T, Shoji M, Tomita N, Furukawa K, Arai H, Asada T,
et al: Lack of genetic association between TREM2 and late-onset
Alzheimer's disease in a Japanese population. J Alzheimers Dis.
41:1031–1038. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Jin SC, Benitez BA, Karch CM, Cooper B,
Skorupa T, Carrell D, Norton JB, Hsu S, Harari O, Cai Y, et al:
Coding variants in TREM2 increase risk for Alzheimer's disease. Hum
Mol Genet. 23:5838–5846. 2014.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Jiang T, Tan L, Chen Q, Tan MS, Zhou JS,
Zhu XC, Lu H, Wang HF, Zhang YD and Yu JT: A rare coding variant in
TREM2 increases risk for Alzheimer's disease in Han Chinese.
Neurobiol Aging. 42:217.e1–e3. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Dardiotis E, Siokas V, Pantazi E, Dardioti
M, Rikos D, Xiromerisiou G, Markou A, Papadimitriou D, Speletas M
and Hadjigeorgiou GM: A novel mutation in TREM2 gene causing
Nasu-Hakola disease and review of the literature. Neurobiol Aging.
53:194.e13–194.e22. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Mehrjoo Z, Najmabadi A, Abedini SS,
Mohseni M, Kamali K, Najmabadi H and Khorram Khorshid HR:
Association study of the TREM2 gene and identification of a novel
variant in exon 2 in iranian patients with late-onset Alzheimer's
disease. Med Prin Pract. 24:351–354. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Peplonska B, Berdynski M, Mandecka M,
Barczak A, Kuzma-Kozakiewicz M, Barcikowska M and Zekanowski C:
TREM2 variants in neurodegenerative disorders in the Polish
population. Homozygosity and compound heterozygosity in FTD
patients. Amyotroph Lateral Scler Frontotemporal Degener.
19:407–412. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Arboleda-Bustos CE, Ortega-Rojas J,
Mahecha MF, Arboleda G, Vásquez R, Pardo R and Arboleda H: The
p.R47H variant of TREM2 gene is associated with late-onset
Alzheimer disease in Colombian population. Alzheimer Dis Assoc
Disord. 32:305–308. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Stang A: Critical evaluation of the
Newcastle-Ottawa scale for the assessment of the quality of
nonrandomized studies in meta-analyses. Eur J Epidemiol.
25:603–605. 2010.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yu JT, Jiang T, Wang YL, Wang HF, Zhang W,
Hu N and Tan L, Sun L, Tan MS, Zhu XC and Tan L: Triggering
receptor expressed on myeloid cells 2 variant is rare in late-onset
Alzheimer's disease in Han Chinese individuals. Neurobiol Aging.
35:937.e1–e3. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chung SJ, Kim MJ, Kim J, Kim YJ, You S,
Koh J, Kim SY and Lee JH: Exome array study did not identify novel
variants in Alzheimer's disease. Neurobiol Aging. 35:1958.e13–e14.
2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ma J, Zhou Y, Xu J, Liu X, Wang Y, Deng Y,
Wang G, Xu W, Ren R, Liu X, et al: Association study of TREM2
polymorphism rs75932628 with late-onset Alzheimer's disease in
Chinese Han population. Neurol Res. 36:894–896. 2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Jiao B, Liu X, Tang B, Hou L, Zhou L,
Zhang F, Zhou Y, Guo J, Yan X and Shen L: Investigation of TREM2,
PLD3, and UNC5C variants in patients with Alzheimer's disease from
mainland China. Neurobiol Aging. 35:2422.e9–2422.e11.
2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang P, Guo Q, Zhou Y, Chen K, Xu Y, Ding
D, Hong Z and Zhao Q: Lack of association between triggering
receptor expressed on myeloid cells 2 polymorphism rs75932628 and
late-onset Alzheimer's disease in a Chinese Han population.
Psychiat Genet. 28:16–18. 2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Giraldo M, Lopera F, Siniard AL,
Corneveaux JJ, Schrauwen I, Carvajal J, Muñoz C, Ramirez-Restrepo
M, Gaiteri C, Myers AJ, et al: Variants in triggering receptor
expressed on myeloid cells 2 are associated with both behavioral
variant frontotemporal lobar degeneration and Alzheimer's disease.
Neurobiol Aging. 34:2077.e11–e18. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bertram L, Parrado AR and Tanzi RE: TREM2
and neurodegenerative disease. N Engl J Med.
369(1565)2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tosto G, Vardarajan B, Sariya S, Brickman
AM, Andrews H, Manly JJ, Schupf N, Reyes-Dumeyer D, Lantigua R,
Bennett DA, et al: Association of variants in PINX1 and TREM2 with
late-onset Alzheimer disease. JAMA Neurol. 76:942–948.
2019.PubMed/NCBI View Article : Google Scholar : (Online ahead of
print).
|
|
26
|
Sirkis DW, Bonham LW, Aparicio RE, Geier
EG, Ramos EM, Wang Q, Karydas A, Miller ZA, Miller BL, Coppola G
and Yokoyama JS: Rare TREM2 variants associated with Alzheimer's
disease display reduced cell surface expression. Acta Neuropathol
Commun. 4(98)2016.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Pottier C, Wallon D, Rousseau S,
Rovelet-Lecrux A, Richard AC, Rollin-Sillaire A, Frebourg T,
Campion D and Hannequin D: TREM2 R47H variant as a risk factor for
early-onset Alzheimer's disease. J Alzheimers Dis. 35:45–49.
2013.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Benitez BA, Cooper B, Pastor P, Jin SC,
Lorenzo E, Cervantes S and Cruchaga C: TREM2 is associated with the
risk of Alzheimer's disease in Spanish population. Neurobiol Aging.
34:1711.e15–e17. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gonzalez Murcia JD, Schmutz C, Munger C,
Perkes A, Gustin A, Peterson M, Ebbert MT, Norton MC, Tschanz JT,
Munger RG, et al: Assessment of TREM2 rs75932628 association with
Alzheimer's disease in a population-based sample: The cache county
study. Neurobiol Aging. 34:2889.e11–e13. 2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ruiz A, Dols-Icardo O, Bullido MJ, Pastor
P, Rodríguez-Rodríguez E, López de Munain A, de Pancorbo MM,
Pérez-Tur J, Alvarez V, Antonell A, et al: Assessing the role of
the TREM2 p.R47H variant as a risk factor for Alzheimer's disease
and frontotemporal dementia. Neurobiol Aging. 35:444.e1–e4.
2014.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Cuyvers E, Bettens K, Philtjens S, Van
Langenhove T, Gijselinck I, van der Zee J, Engelborghs S,
Vandenbulcke M, Van Dongen J, Geerts N, et al: Investigating the
role of rare heterozygous TREM2 variants in Alzheimer's disease and
frontotemporal dementia. Neurobiol Aging. 35:726.e11–e19.
2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Slattery CF, Beck JA, Harper L, Adamson G,
Abdi Z, Uphill J, Campbell T, Druyeh R, Mahoney CJ, Rohrer JD, et
al: R47H TREM2 variant increases risk of typical early-onset
Alzheimer's disease but not of prion or frontotemporal dementia.
Alzheimers Dement. 10:602–608.e4. 2014.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Finelli D, Rollinson S, Harris J, Jones M,
Richardson A, Gerhard A, Snowden J, Mann D and Pickering-Brown S:
TREM2 analysis and increased risk of Alzheimer's disease. Neurobiol
Aging. 36:546.e9–e13. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Roussos P, Katsel P, Fam P, Tan W, Purohit
DP and Haroutunian V: The triggering receptor expressed on myeloid
cells 2 (TREM2) is associated with enhanced inflammation,
neuropathological lesions and increased risk for Alzheimer's
dementia. Alzheimers Dement. 11:1163–1170. 2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Rosenthal SL, Bamne MN, Wang X, Berman S,
Snitz BE, Klunk WE, Sweet RA, Demirci FY, Lopez OL and Kamboh MI:
More evidence for association of a rare TREM2 mutation (R47H) with
Alzheimer's disease risk. Neurobiol Aging. 36:2443.e21–e26.
2015.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ghani M, Sato C, Kakhki EG, Gibbs JR,
Traynor B, St George-Hyslop P and Rogaeva E: Mutation analysis of
the MS4A and TREM gene clusters in a case-control Alzheimer's
disease data set. Neurobiol Aging. 42:217.e7–217.e13.
2016.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bellenguez C, Charbonnier C, Grenier-Boley
B, Quenez O, Le Guennec K, Nicolas G, Chauhan G, Wallon D, Rousseau
S, Richard AC, et al: Contribution to Alzheimer's disease risk of
rare variants in TREM2, SORL1, and ABCA7 in 1,779 cases and 1,273
controls. Neurobiol Aging. 59:220.e1–220.e9. 2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Landoulsi Z, Ben Djebara M, Kacem I,
Sidhom Y, Kefi R, Abdelhak S, Gargouri-Berrechid A and Gouider R:
Genetic Analysis of TREM2 variants in tunisian patients with
Alzheimer's disease. Med Prin Pract. 27:317–322. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Dalmasso MC, Brusco LI, Olivar N, Muchnik
C, Hanses C, Milz E, Becker J, Heilmann-Heimbach S, Hoffmann P,
Prestia FA, et al: Transethnic meta-analysis of rare coding
variants in PLCG2, ABI3, and TREM2 supports their general
contribution to Alzheimer's disease. Transl Psychiatry.
9(55)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Ayer AH, Wojta K, Ramos EM, Dokuru D, Chen
JA, Karydas AM, Papatriantafyllou JD, Agiomyrgiannakis D,
Kamtsadeli V, Tsinia N, et al: Frequency of the TREM2 R47H variant
in various neurodegenerative disorders. Alzheimer Dis Assoc Disord.
33:327–330. 2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Jay TR, von Saucken VE and Landreth GE:
TREM2 in neurodegenerative diseases. Mol Neurodegener.
12(56)2017.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Cady J, Koval ED, Benitez BA, Zaidman C,
Jockel-Balsarotti J, Allred P, Baloh RH, Ravits J, Simpson E, Appel
SH, et al: TREM2 variant p.R47H as a risk factor for sporadic
amyotrophic lateral sclerosis. JAMA Neurol. 71:449–453.
2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Rayaprolu S, Mullen B, Baker M, Lynch T,
Finger E, Seeley WW, Hatanpaa KJ, Lomen-Hoerth C, Kertesz A, Bigio
EH, et al: TREM2 in neurodegeneration: Evidence for association of
the p.R47H variant with frontotemporal dementia and Parkinson's
disease. Mol Neurodegener. 8(19)2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Yuan P, Condello C, C Keene D, Wang Y,
Bird TD, Paul SM, Luo W, Colonna M, Baddeley D and Grutzendler J:
TREM2 haplodeficiency in mice and humans impairs the microglia
barrier function leading to decreased amyloid compaction and severe
axonal dystrophy. Neuron. 92:252–264. 2016.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Wang Y, Cella M, Mallinson K, Ulrich JD,
Young KL, Robinette ML, Gilfillan S, Krishnan GM, Sudhakar S,
Zinselmeyer BH, et al: TREM2 lipid sensing sustains the microglial
response in an Alzheimer's disease model. Cell. 160:1061–1071.
2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Lue LF, Schmitz CT, Serrano G, Sue LI,
Beach TG and Walker DG: TREM2 Protein expression changes correlate
with Alzheimer's disease neurodegenerative pathologies in
post-mortem temporal cortices. Brain Pathol. 25:469–480.
2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Cheng Q, Danao J, Talreja S, Wen P, Yin J,
Sun N, Li CM, Chui D, Tran D, Koirala S, et al: TREM2-activating
antibodies abrogate the negative pleiotropic effects of the
Alzheimer's disease variant Trem2R47H on murine myeloid
cell function. J Biol Chem. 293:12620–12633. 2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Kober DL, Alexander-Brett JM, Karch CM,
Cruchaga C, Colonna M, Holtzman MJ and Brett TJ: Neurodegenerative
disease mutations in TREM2 reveal a functional surface and distinct
loss-of-function mechanisms. Elife. 5(e20391)2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Bailey CC, DeVaux LB and Farzan M: The
triggering receptor expressed on myeloid cells 2 binds
apolipoprotein E. J Biol Chem. 290:26033–26042. 2015.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Xiang X, Piers TM, Wefers B, Zhu K,
Mallach A, Brunner B, Kleinberger G, Song W, Colonna M, Herms J, et
al: The Trem2 R47H Alzheimer's risk variant impairs splicing and
reduces Trem2 mRNA and protein in mice but not in humans. Mol
Neurodegener. 13(49)2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Cheng-Hathaway PJ, Reed-Geaghan EG, Jay
TR, Casali BT, Bemiller SM, Puntambekar SS, von Saucken VE,
Williams RY, Karlo JC, Moutinho M, et al: The Trem2 R47H variant
confers loss-of-function-like phenotypes in Alzheimer's disease.
Mol Neurodegener. 13(29)2018.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Yeh FL, Wang Y, Tom I, Gonzalez LC and
Sheng M: TREM2 binds to apolipoproteins, including APOE and
CLU/APOJ, and thereby facilitates uptake of amyloid-beta by
microglia. Neuron. 91:328–340. 2016.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Song W, Hooli B, Mullin K, Jin SC, Cella
M, Ulland TK, Wang Y, Tanzi RE and Colonna M: Alzheimer's
disease-associated TREM2 variants exhibit either decreased or
increased ligand-dependent activation. Alzheimer Dement.
13:381–387. 2017.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ghani M, Lang AE, Zinman L, Nacmias B,
Sorbi S, Bessi V, Tedde A, Tartaglia MC, Surace EI, Sato C, et al:
Mutation analysis of patients with neurodegenerative disorders
using NeuroX array. Neurobiol Aging. 36:545.e9–e14. 2015.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Schlepckow K, Kleinberger G, Fukumori A,
Feederle R, Lichtenthaler SF, Steiner H and Haass C: An
Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site
and affects shedding and phagocytic function. EMBO Mol Med.
9:1356–1365. 2017.PubMed/NCBI View Article : Google Scholar
|
